No.	Recommendations/Statements	GoR	LoE	Sources
8.10. modified 2021	Consensus-based recommendation In stage IA1 without any risk factors, treatment must be administered as follows: Surgery: Lymph-node removal is not indicated. If family planning has been completed, or if the patient wishes greater certainty: Simple hysterectomy. If the patient wishes to have children: Conization (within healthy margins) with cervical curettage. If there are positive margins in the conization specimen (R1): Repeat conization, or Trachelectomy (within healthy margins, with prophylactic permanent cerclage). Following successful pregnancy: Secondary hysterectomy is possible, particularly if there is persistent HPV, abnormal Pap findings, if the patient wishes maximum safety, or if the cervix is difficult or impossible to assess. Radio(chemo)therapy: Not indicated.	EC
8.11. new 2021	Consensus-based recommendation In stage IA1 with lymphatic infiltration (L1), treatment must be administered as follows: Surgery: Sentinel lymphadenectomy is indicated. If family planning has been completed, or if the patient wishes greater certainty: Simple hysterectomy. If the patient wishes to have children: Conization (within healthy margins) with cervical curettage. If there are positive margins in the conization specimen (R1): Repeat conization, or Trachelectomy (within healthy margins, with prophylactic permanent cerclage). Following successful pregnancy: Secondary hysterectomy is possible, particularly if there is persistent HPV, abnormal Pap findings, if the patient wishes maximum safety, or if the cervix is difficult or impossible to assess. Radio(chemo)therapy: Not indicated.	EC
8.12. modified 2021	Consensus-based recommendation In stage IA1 with at least two risk factors, and stage IA2 with up to one risk factor, treatment should be administered as follows: Surgery: If the patient does not wish to have children and if she wants to be particularly safe and has histologically negative lymph nodes (pelvic) after surgical staging with SNB: Hysterectomy (with bilateral adnexectomy if appropriate), without resection of the parametria (Piver I) If the patient wishes to have children and has negative lymph nodes after surgical staging with SNB: Conization with cervical curettage or Radical trachelectomy with prophylactic permanent cerclage. If there are sentinel lymph nodes affected by tumor, or there are pelvic lymph-node metastases: Para-aortic lymphadenectomy (surgical staging). In premenopausal patients: Ovariopexy to maintain intrinsic ovarian function. If there are macroscopically tumor-affected pelvic and/or para-aortic lymph nodes: Surgical removal before radio(chemo)therapy. After successful pregnancy: Secondary hysterectomy, particularly when there is persistent HPV infection, Pap abnormalities, if the patient wants greater safety, and if the cervix can only be assessed to a limited extent or not at all. Radio(chemo)therapy: If there is histological evidence of pelvic and/or para-aortic lymph-node metastases or there are several risk factors: R(CH)T in the histologically confirmed area of spread.	EC
8.13. modified 2021	Consensus-based recommendation In stage IA2 with at least two risk factors, treatment should be administered as follows: Surgery (preserving fertility is not possible) with SNB: With negative lymph nodes (pelvic) after surgical staging: Radical hysterectomy (with bilateral adnexectomy if appropriate), with resection of the parametria (Piver II) If there are sentinel lymph nodes affected by tumor or if there are pelvic lymph-node metastases: Additional para-aortic lymphadenectomy (surgical staging). In premenopausal patients: Ovariopexy to maintain intrinsic ovarian function. If there are macroscopically tumor-affected pelvic and/or para-aortic lymph nodes: Surgical removal of these before radio(chemo)therapy. Radio(chemo)therapy: If there is histological evidence of pelvic and/or para-aortic lymph-node metastases or there are several risk factors: R(CH)T in the histologically confirmed area of spread.	EC